首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   585篇
  免费   26篇
  国内免费   32篇
  2024年   3篇
  2023年   14篇
  2022年   18篇
  2021年   27篇
  2020年   17篇
  2019年   16篇
  2018年   32篇
  2017年   18篇
  2016年   13篇
  2015年   21篇
  2014年   29篇
  2013年   51篇
  2012年   22篇
  2011年   34篇
  2010年   32篇
  2009年   33篇
  2008年   43篇
  2007年   32篇
  2006年   29篇
  2005年   24篇
  2004年   16篇
  2003年   12篇
  2002年   16篇
  2001年   7篇
  2000年   3篇
  1999年   9篇
  1998年   6篇
  1997年   6篇
  1996年   3篇
  1995年   5篇
  1994年   1篇
  1993年   4篇
  1992年   4篇
  1991年   4篇
  1990年   4篇
  1989年   4篇
  1987年   2篇
  1985年   4篇
  1984年   5篇
  1983年   3篇
  1982年   4篇
  1981年   4篇
  1980年   5篇
  1979年   1篇
  1977年   1篇
  1976年   1篇
  1970年   1篇
排序方式: 共有643条查询结果,搜索用时 15 毫秒
101.

Background

Visceral fat (VF) accretion is a hallmark of aging in humans. Epidemiologic studies have implicated abdominal obesity as a major risk factor for insulin resistance, type 2 diabetes, cardiovascular disease, metabolic syndrome and death.

Methods

Studies utilizing novel rodent models of visceral obesity and surgical strategies in humans have been undertaken to determine if subcutaneous (SC) abdominal or VF are causally linked to age-related diseases.

Results

Specific depletion or expansion of the VF depot using genetic or surgical tools in rodents has been shown to have direct effects on disease risk. In contrast, surgically removing large quantities of SC fat does not consistently improve metabolic parameters in humans or rodents, while benefits were observed with SC fat expansion in mice, suggesting that SC fat accrual is not an important contributor to metabolic decline. There is also compelling evidence in humans that abdominal obesity is a stronger risk factor for mortality risk than general obesity. Likewise, we have shown that surgical removal of VF improves mean and maximum lifespan in rats, providing the first causal evidence that VF depletion may be an important underlying cause of improved lifespan with caloric restriction.

General significance

This review provides both corollary and causal evidence for the importance of accounting for body fat distribution, and specifically VF, when assessing disease and mortality risk. Given the hazards of VF accumulation on health, treatment strategies aimed at selectively depleting VF should be considered as a viable tool to effectively reduce disease risk in humans.  相似文献   
102.
103.
采用细胞转染、油红O染色、油红O染色提取法、GPDH活性测定、semi-qRT-PCR等方法研究了视黄酸X受体α (retinoic acid X receptor α, RXRα)在猪原代前体脂肪细胞分化中的作用及其机理.结果表明,转染pRXRα-EGFP促进了猪前体脂肪细胞RXRα 的表达,脂肪细胞分化能力随之增强, 脂肪细胞GPDH活性、分化转录因子PPARγ和C/EBPαmRNA表达水平均显著升高(P<0.05). 结果提示,RXRα可能通过调控过氧化物酶体增殖物激活受体γ(peroxisome proliferators-activated receptor-γ, PPARγ)和CAAT/增强子结合蛋白家族(CCAAT/enhancer binding proteins, C/EBP)C/EBPα 基因表达变化促进猪前体脂肪细胞分化.  相似文献   
104.
Background  Monocyte chemoattractant protein-1 (MCP-1) is an inflammatory chemokine known to induce adipocyte dedifferentiation and insulin resistance. Inflammation, insulin resistance, and obesity have been implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Methods  Fasting plasma from 43 baboons were assayed for MCP-1, insulin, glucose, alanine aminotransferase (ALT), and aspartate aminotransferase (AST). Adipocyte number and volume were measured via biopsies of omental adipose tissue. The homeostatic model assessment method (HOMA) was used to estimate systemic insulin resistance.
Results  Sex and age adjusted correlations were significant for MCP-1 with adipocyte number (r = −0.42; P  = 0.01), adipocyte volume (r = 0.38; P  = 0.02), HOMA (r = 0.45; P  = 0.004), ALT (r = 0.46; P  = 0.03) and AST (r = 0.45; P  = 0.03).
Conclusions  These results suggest that MCP-1 is related with adipocyte dedifferentiation and systemic insulin resistance, thereby potentially contributing to the development of NAFLD.  相似文献   
105.
106.
107.
108.
109.
Gao Y  Zhang YH  Zhang S  Li F  Wang S  Dai L  Jiang H  Xiao S  Liu D  Sun B  Zhao Z  Zhang JB 《Gene》2011,487(2):170-173
This study was designed to investigate the single nucleotide polymorphism (SNP) in intron 1 of the gene A-FABP in 127 Junmu No. 1 white swine using PCR-SSCP. The association between the polymorphism and meat quality traits was also studied. The cloning and sequencing results indicated that the polymorphism of intron 1 was due to a point mutation in position 3481 bp of A-FABP, giving 3 genotypes (CC, CD and DD). Association analysis indicated that the polymorphism had a significant effect on marbling (P < 0.05). Genotype DD had higher marbling than CD and CC, but the difference between CD and CC was no significant. Polymorphism had a highly significant effect on intramuscular fat (IMF) content (P < 0.01). DD was higher than CD, which was higher than CC. No significant conclusions can be drawn regarding other traits. Immunoblot analysis of A-FABP levels was carried out on 3 different genotype individuals. Expression was markedly reduced in DD compared with genotype CC. Thus A-FABP may be a candidate gene or a quantitative trait locus-linked gene associated with meat quality traits.  相似文献   
110.
Dietary and xenobiotic compounds may alter endocrine signaling and lipid homeostasis, thus inducing obesity. We describe a short-term assay method, the zebrafish obesogenic (ZO) test, for examining the effects of diet, drugs, and environmental contaminants, singly or in combination, on white adipose tissue (WAT) dynamics in live larvae. The ZO test is an intermediate step in obesity research, between in vitro and rodent assays, and may be also used to study the effect of environmental toxicants on the adiposity of aquatic species. The procedure, using Nile Red (NR) fluorescent probe to reveal adipocyte lipid droplets, is suitable for pharmaceutical or toxicological screening. Larvae treated at an environmentally-relevant concentration of tributyltin chloride (TBT), an environmental obesogen, exhibited a remarkable increase in adiposity, irrespective of the lipid composition of the background diet. Exogenous compounds, e.g., rosiglitazone or TBT, known to increase adiposity in the fasting state, were classified as obesogenic. Anti-obesogenic compounds favored a decrease in adiposity in the fasting state. The ZO test, using adipocyte lipid droplet size and adiposity as its endpoints, is a whole-organism alternative testing assay for obesogenic and anti-obesogenic compounds and mixtures and provides relevant information for environmental and human risk assessments.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号